How the 4T Program Is Helping Young People Manage Type 1 Diabetes Better

When someone is newly diagnosed with Type 1 diabetes, the first weeks and months are critical. Getting good blood sugar control early can make a real difference in long-term health. A program called the 4T Program—which stands for Teamwork, Targets, and Technology for Tight Glycemia—is designed to help young people achieve this from day one.

The 4T Program combines three key elements: continuous glucose monitors (CGMs), which track blood sugar 24/7; remote patient monitoring, which lets healthcare teams keep watch from a distance; and coordinated teamwork between patients and providers. Researchers tested this approach with 451 young people across three different clinical settings and found it worked well.

Getting a new diabetes program up and running isn't just about the science—it's about making it work in the real world. Researchers identified several major hurdles. Clinicians had limited time to monitor patients closely. Families worried about costs. Clinics needed to manage resources carefully.

To tackle these challenges, the 4T Program developed the Timely Interventions for Diabetes Excellence (TIDE) tool, a clinical decision support system that helps doctors focus their attention on the patients who need it most. Rather than checking in with everyone equally, the tool helps identify who would benefit most from closer monitoring. The program also worked to address family costs and clinic resources, recognizing that a good program needs to fit into real healthcare settings.

Starting a program at one hospital is one thing. Spreading it across many clinics is another. After proving the 4T Program worked in early studies, researchers began exploring how to scale it up through the T1D Exchange Quality Improvement Collaborative—a network designed to help many centers improve care together.

The research team used implementation science, a field focused on getting proven programs to work in different settings. They studied which strategies worked best to overcome barriers and help both young people and healthcare providers adopt the program. This careful, strategic approach aims to make sure that the benefits seen in early testing can reach more youth with Type 1 diabetes.

Source: Journal of clinical & translational endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.